Practical issues in drug selection and dosing

H W Schnaper1

  • 1Department of Medicine, University of Alabama, Birmingham 35294.

Insights

Current guidelines suggest nonpharmacologic treatment for hypertension initially. Drug therapy is recommended for persistent high blood pressure, with specific first-line options for different patient groups, prioritizing safety and efficacy.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertension management guidelines recommend initiating antihypertensive therapy at diastolic blood pressure >90 mm Hg after nonpharmacologic measures fail.
  • Elevated blood pressure, whether systolic, diastolic, or both, increases the risk of heart attack and stroke.

Purpose of the Study:

  • To outline current recommendations for initiating antihypertensive therapy.
  • To detail the initial approach for managing mild to moderate hypertension and for prevention in normotensive individuals with a family history.
  • To specify first-line drug choices and titration strategies based on patient demographics and comorbidities.

Main Methods:

  • Review of current clinical guidelines for hypertension management.
  • Analysis of evidence supporting nonpharmacologic and pharmacologic interventions.
  • Stratification of treatment recommendations by patient age, blood pressure profile, and specific conditions like tachycardia.

Main Results:

  • Nonpharmacologic measures are the initial approach for mild to moderate hypertension and in prevention programs.
  • For patients remaining hypertensive, drug therapy is indicated.
  • Low-dose thiazide diuretics are preferred for elderly patients; beta-blockers may be considered for patients under 40 with tachycardia.
  • Treatment initiation should be with less than a full dose, titrating as necessary.
  • Potassium-sparing diuretics are recommended if extrasystoles or low potassium levels (<3.5 mEq/L) occur in the elderly.

Conclusions:

  • Current guidelines provide a stepwise approach to hypertension management, starting with nonpharmacologic methods.
  • Pharmacologic therapy selection and titration should be individualized based on patient characteristics.
  • Careful monitoring of electrolytes, particularly potassium, is crucial during diuretic therapy to mitigate risks like arrhythmias.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...